1. Home
  2. RNAZ vs CLRO Comparison

RNAZ vs CLRO Comparison

Compare RNAZ & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • CLRO
  • Stock Information
  • Founded
  • RNAZ 2016
  • CLRO 1983
  • Country
  • RNAZ United States
  • CLRO United States
  • Employees
  • RNAZ N/A
  • CLRO N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • RNAZ Health Care
  • CLRO Technology
  • Exchange
  • RNAZ Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • RNAZ 8.7M
  • CLRO 9.3M
  • IPO Year
  • RNAZ 2021
  • CLRO N/A
  • Fundamental
  • Price
  • RNAZ $14.80
  • CLRO N/A
  • Analyst Decision
  • RNAZ Strong Buy
  • CLRO
  • Analyst Count
  • RNAZ 1
  • CLRO 0
  • Target Price
  • RNAZ $280.00
  • CLRO N/A
  • AVG Volume (30 Days)
  • RNAZ 387.0K
  • CLRO 51.8K
  • Earning Date
  • RNAZ 11-13-2025
  • CLRO 11-14-2025
  • Dividend Yield
  • RNAZ N/A
  • CLRO N/A
  • EPS Growth
  • RNAZ N/A
  • CLRO N/A
  • EPS
  • RNAZ N/A
  • CLRO N/A
  • Revenue
  • RNAZ N/A
  • CLRO $9,689,000.00
  • Revenue This Year
  • RNAZ N/A
  • CLRO N/A
  • Revenue Next Year
  • RNAZ N/A
  • CLRO N/A
  • P/E Ratio
  • RNAZ N/A
  • CLRO N/A
  • Revenue Growth
  • RNAZ N/A
  • CLRO N/A
  • 52 Week Low
  • RNAZ $6.15
  • CLRO $3.83
  • 52 Week High
  • RNAZ $739.20
  • CLRO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 84.37
  • CLRO 60.84
  • Support Level
  • RNAZ $10.32
  • CLRO $5.53
  • Resistance Level
  • RNAZ $12.28
  • CLRO $6.14
  • Average True Range (ATR)
  • RNAZ 0.87
  • CLRO 0.46
  • MACD
  • RNAZ 0.57
  • CLRO 0.06
  • Stochastic Oscillator
  • RNAZ 91.34
  • CLRO 41.80

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: